Mistakes to Be Avoided When Preparing a Drug Launch
The launch of a new product can be a daunting task. The main reason this happens is that no matter […]
Mistakes to Be Avoided When Preparing a Drug Launch Read Post »
Insights
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984
This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under
Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 Read Post »
Customer Success: How do we identify generic entrants before they get FDA approval?
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants
Customer Success: How do we identify generic entrants before they get FDA approval? Read Post »
DrugPatentWatch Headlines Swissbiotech Annual Report
The latest Swiss Biotech annual report focuses on the theme of shaping change. Change is a theme DrugPatentWatch is very
DrugPatentWatch Headlines Swissbiotech Annual Report Read Post »
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection
This article was originally published by Christopher M. Holman* in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection Read Post »
Insights
The Influence of Emerging Markets on the Pharmaceutical Industry
This paper was originally published by Maya Tannoury and Zouhair Attieh in Current Therapeutic Research under a creative commons license.
The Influence of Emerging Markets on the Pharmaceutical Industry Read Post »
Insights
Alternative Data for Biotechnology and Pharmaceutical Financial Modeling and Time Series Analysis
BUILD AND BACKTEST YOUR FINANCIAL MODELS WITH ANNOTATED DRUG PATENTS, SALES, AND LITIGATION Apply your financial models to our
Reviving a Discontinued Drug
When drugs are taken off the market because of concerns about their safety, it makes headlines. To access DrugPatentWatch’s list
Finding and Evaluating Branded and Generic Market Entry Opportunities
Here’s a copy of the recent talk on Finding and Evaluating Branded and Generic Market Entry Opportunities. It’s based on
Finding and Evaluating Branded and Generic Market Entry Opportunities Read Post »
